Debates between Kit Malthouse and Carol Monaghan during the 2017-2019 Parliament

Oral Answers to Questions

Debate between Kit Malthouse and Carol Monaghan
Monday 5th February 2018

(6 years, 9 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Kit Malthouse Portrait Kit Malthouse
- Hansard - -

We have to recognise that we are dealing with support for people who are accumulating what is often a very significant capital asset, and it seems only right that when equity becomes available the taxpayer is able to recover some or all of the support. There has been significant communication on the scheme with the people who are participating in it, and that is continuing. There will be between four and six written communications, and people will be invited to call a telephone number where they can obtain information from a third-party adviser before we get to April, when the scheme comes into play. I am confident that the people who are participating in the scheme at the moment will have enough information. Certainly, large numbers are making a decision either way at the moment.

Carol Monaghan Portrait Carol Monaghan (Glasgow North West) (SNP)
- Hansard - - - Excerpts

I have been contacted by a number of constituents about this issue, including a Mr Milne, a veteran who is surviving just now on a meagre state pension. He fears that this change will force him to sell his house or to have it repossessed. What assessment has the Minister made of the impact of this change, particularly on pensioners?

Kit Malthouse Portrait Kit Malthouse
- Hansard - -

There is absolutely no reason for anybody to fear forced sale or repossession of a house, not least because the scheme is specifically designed to avoid exactly that. If Members have specific cases where constituents have concerns about the operation of the scheme, I will be more than happy to take them up. If the hon. Lady writes to me about that case, I will provide a response.

Euratom Membership

Debate between Kit Malthouse and Carol Monaghan
Wednesday 12th July 2017

(7 years, 4 months ago)

Westminster Hall
Read Full debate Read Hansard Text Read Debate Ministerial Extracts

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Carol Monaghan Portrait Carol Monaghan
- Hansard - - - Excerpts

Absolutely. I do not know about all the European Court judgments, but that certainly is not something that many of us have heard anything about. Euratom has operated very successfully for 60 years, but now we seem to be taking ourselves out of the regulatory framework.

Kit Malthouse Portrait Kit Malthouse
- Hansard - -

Will the hon. Lady give way?

Carol Monaghan Portrait Carol Monaghan
- Hansard - - - Excerpts

No, I am going to make some progress.

Any future negotiations on whatever membership of Euratom we might have—I hope that it is full membership, but there could be associate membership—must include the Scottish Government, as they are dealing with the regulation of nuclear facilities in Scotland. Some people have talked about putting our own regulatory framework in place. Of course, we could get our own regulations in place, but the problem is that the clock is ticking, we do not have a lot of time and producing these frameworks takes many years, not 20 months. That is a real issue.

A number of hon. Members have mentioned medical isotopes. The Euratom Supply Agency ensures the security of supply of medical isotopes for all members of Euratom. My hon. Friend the Member for Central Ayrshire (Dr Whitford) gave us some statistics. She said that 500,000 diagnostic scans and 10,000 cancer treatments are carried out annually as a result of those isotopes. However, we cannot produce our own medical isotopes and must therefore import them. Medical isotopes have very short half-lives, which means they need to be transported quickly, and there are only a few facilities in the world that produce them. A number of the reactors that produce medical isotopes are coming to the end of their useful lifespan, which means that in future there could be real problems with their supply worldwide anyway. This is not the time to take ourselves out of the agency that ensures that we have a supply.